4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-20-007687
Options or other derivatives
- Exec. Director, Finance - PAO acquired 2,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Jones Michael L · Exec. Director, Finance - PAO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-21 | Grant or award : show line 1 in the form Emp. Stock Option (Right to Buy) | +2,800 | 2,800 | D |
Loading xslF345X03/form4.xml…